H. Curé

Multicentre, phase II study evaluating capecitabine monotherapy in patients with anthracycline- and taxane-pretreated metastatic breast cancer

P. Fumoleau, R. Largillier, Christine Clippe et al. · European Journal of Cancer · 2003 · 307 citations

Breast Oncology, Oncology, Medicine +6

Prognostic significance of a complete pathological response after induction chemotherapy in operable breast cancer

P. Chollet, S. Amat, H. Curé et al. · British Journal of Cancer · 2002 · 255 citations · Full text

Validation of the G8 screening tool in geriatric oncology: The ONCODAGE project.

Pierre Soubeyran, Carine Bellera, Jean Goyard et al. · Journal of Clinical Oncology · 2011 · 156 citations

Cancer Management, Epidemiology Of Cancer, Pathology +18

Single agent activity of oxaliplatin in heavily pretreated advanced epithelial ovarian cancer

P. Chollet, M.A. Bensmaïne, S. Brienza et al. · Annals of Oncology · 1996 · 140 citations

Oncology, Medicine, Pharmacology +6

6 months versus 12 months of adjuvant trastuzumab in early breast cancer (PHARE): final analysis of a multicentre, open-label, phase 3 randomised trial

Xavier Pivot, Gilles Romieu, Marc Debled et al. · The Lancet · 2019 · 125 citations

Breast Oncology, Oncology, Early Breast Cancer +6